secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0001493152-23-006000
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech enters $75M at-the-market equity offering agreement with Cantor Fitzgerald
--------------------------------------------------------------------------------

- Up to $75M of common stock may be sold from time to time through Cantor Fitzgerald & Co.
- Cantor receives a 3.0% commission on gross proceeds from each sale.
- Sales are at-the-market offerings under Rule 415(a)(4); no obligation to sell any shares.
- Agreement may be suspended or terminated by either party upon notice.
- Shares are registered under existing S-3 shelf registration statement (File No. 333-251652).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315223006000/0001493152-23-006000-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315223006000/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-006000

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer